Dosar de subiect

Altele

MAK Capital Urges Evotec to List US Unit Valued Over €1 Billion

Primul articol: 6 apr. 2026, 22:37 | Ultima actualizare: 6 apr. 2026, 22:37 | 1 sursa | 1 articol
#makcapital#evotec#listing#economy

Mai multe surse. Mai putina manipulare.

Analiza editoriala

Bazat pe 1 sursa, 1 articol

MAK Capital, an investment firm, is advocating for Evotec, a drug discovery and development company, to pursue a listing of its US-based unit. MAK Capital believes the US unit is significantly undervalued within the larger Evotec structure and estimates its worth to be in excess of €1 billion. A separate listing could unlock value for shareholders.

Articole despre acest subiect

MAK Capital Tells Evotec to List US Unit Worth Over €1 billion Foto: Bloomberg
Bloomberg English Eyk Henning 6 apr. 2026, 22:37 (acum 2 ore)

MAK Capital Tells Evotec to List US Unit Worth Over €1 billion

Activist fund MAK Capital, led by Michael A. Kaufman, has urged the leadership of German biotech firm Evotec SE to list its US unit and speed up its cost cutting program after the shares have lost about 85% over the past five years.

Citeste pe Bloomberg →